Cargando…
Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosis
From January 1(st) 2013 to August 31(st) 2016, 24408 pregnant women received the first trimester Combined test and contingently offered second trimester maternal serum screening to identify those women who would most benefit from invasive prenatal diagnosis (IPD). The screening was based on first tr...
Autores principales: | Guanciali Franchi, Paolo, Palka, Chiara, Morizio, Elisena, Sabbatinelli, Giulia, Alfonsi, Melissa, Fantasia, Donatella, Sitar, Giammaria, Benn, Peter, Calabrese, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720779/ https://www.ncbi.nlm.nih.gov/pubmed/29216282 http://dx.doi.org/10.1371/journal.pone.0189235 |
Ejemplares similares
-
Aneuploidy screening using circulating fetal cells in maternal blood by dual‐probe FISH protocol: a prospective feasibility study on a series of 172 pregnant women
por: Calabrese, Giuseppe, et al.
Publicado: (2016) -
Isolation and Enrichment of Circulating Fetal Cells for NIPD: An Overview
por: Sabbatinelli, Giulia, et al.
Publicado: (2021) -
Non-invasive prenatal screening: A 20-year experience in Italy
por: Palka, Chiara, et al.
Publicado: (2019) -
First case of two supernumerary markers derived from chromosome 5 and chromosome 8
por: Giansante, Roberta, et al.
Publicado: (2022) -
Mayer-Rokitansky-Küster-Hauser syndrome with 22q11.21 microduplication: a case report
por: Dell’Edera, Domenico, et al.
Publicado: (2021)